- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05504018
Clinical and Radiological Evaluation of ACL Reconstruction Results
Clinical and Radiological Evaluation of Anterior Cruciate Ligament Reconstruction Surgery With Follow-up at Least 1 Year
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The literature presents a number of studies on the reconstruction of the anterior cruciate ligament, as well as numerous registers, but the identification of factors and parameters determining the outcomes remains largely debated. The study aims to analyze the potentially individual and operative parameters and identify the factors responsible for the clinical and radiological outcomes. In addition to collecting patient data in terms of features and clinical-radiological status, objective data will be documented and correlated.
The study is intended to include all patients who will undergo surgical reconstruction of the anterior cruciate ligament (ACL). These patients will be followed and evaluated preoperatively, at 6 months and at 1 years after surgery during a clinical visit. Such assessments will include the patient reported outcomes, the objective examination of the knee during a medical examination to quantify its stability and the radiological examination.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Samsun, Turkey
- Ahmet E. Okutan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients who have provided informed written written consent;
- Patients aged between 18 and 45;;
- Patients undergoing reconstructive surgical treatment of the anterior cruciate ligament (ACL)
Exclusion Criteria:
- Patients who have not signed informed consent;
- Patients undergoing any additional concomitant ligament repair or reconstruction at the same surgery
- Revision procedures
- Patients unable to lay still in an MRI or CT scanner
- Patients with a torn ACL or previous ACL reconstruction in the contralateral knee.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Magnetic Resonance Imaging (MRI) of Graft
Time Frame: 1 year
|
Graft maturation on MRI using T2 Turbo Spin Echo (TSE) sequence without fat saturation
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in Computed Tomography (CT) imaging of Tunnels
Time Frame: 1 day, 6 months, 1 year
|
Femoral and Tibial Tunnel Morphological Changes
|
1 day, 6 months, 1 year
|
|
International Knee Documentation Committee (IKDC)
Time Frame: 1 year
|
Patient reported outcome measures of symptoms, sports activity & knee function.
0-100 points with 0 (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms)
|
1 year
|
|
Marx Activity Rating Score
Time Frame: 1 year
|
Clinical Outcomes
|
1 year
|
|
Isokinetic Dynamometer
Time Frame: 1 year
|
Measurement of knee extension and flexion torque using the isokinetic dynamometer
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ahmet Emin Okutan, MD, Samsun University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AEOACL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.